Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab

Cindy X. Cai, Patrick Ryan, Evan Minty et al.|Ophthalmology Retina|2024

Cited by 16